CompletedNot Applicable

A Non-interventional, Observational Study for Targinact® Treatment in Patients With Chronic Severe Pain

Belgium68 participantsStarted 2012-09

Plain-language summary

This non-interventional, observational study is set up on request of the Belgian reimbursement authorities and evaluates the efficacy of Targinact with regard to pain relief and constipation in daily clinical practice in Belgium compared to the previous analgesic treatment with prolonged release oxycodone. Only patients eligible for Targinact® reimbursement in Belgium are included.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria: patients included are patients who * are eligible for Targinact® treatment according to the Targinact® SPC AND * who have previously been treated with PR oxycodone during at least the last 30 days before study inclusion AND * who are constipated (BFI \> 30) AND * have used at least 2 laxatives with different modes of action during the previous PR oxycodone treatment Exclusion criteria are based on Targinact® SPC.

What they're measuring

Percentage of responders after Targinact treatment compared to the previous treatment with prolonged release oxycodone.

Timeframe: 12 weeks

Trial details

NCT IDNCT01710904

SponsorMundipharma CVA

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2013-07

View on ClinicalTrials.gov More Chronic Severe Pain trials